[go: up one dir, main page]

MA30035B1 - Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane - Google Patents

Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane

Info

Publication number
MA30035B1
MA30035B1 MA31011A MA31011A MA30035B1 MA 30035 B1 MA30035 B1 MA 30035B1 MA 31011 A MA31011 A MA 31011A MA 31011 A MA31011 A MA 31011A MA 30035 B1 MA30035 B1 MA 30035B1
Authority
MA
Morocco
Prior art keywords
treatment
skin
vegetable pulp
insaponifiable
olding
Prior art date
Application number
MA31011A
Other languages
English (en)
Inventor
Bernard Fabre
Rene Belle
Marie Charveron
Caroline Baudouin
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MA30035B1 publication Critical patent/MA30035B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Utilisation d'un extrait insaponifiable de pulpe végétale dans le traitement du vieillissement cutané. Le domaine de la présente invention concerne l'utilisation d'un extrait insaponifiable de pulpe végétale pour la préparation d'un produit cosmétique, pharmaceutique ou nutraceutique destiné à traiter et/ou à prévenir les désordres cutanés associés au vieillissement.
MA31011A 2006-01-05 2008-06-06 Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane MA30035B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0600077A FR2895677B1 (fr) 2006-01-05 2006-01-05 Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillissement cutane.

Publications (1)

Publication Number Publication Date
MA30035B1 true MA30035B1 (fr) 2008-12-01

Family

ID=36991296

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31011A MA30035B1 (fr) 2006-01-05 2008-06-06 Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane

Country Status (18)

Country Link
US (1) US20090012049A1 (fr)
EP (1) EP1968536A2 (fr)
JP (1) JP2009522341A (fr)
KR (1) KR20080083134A (fr)
CN (1) CN101355926B (fr)
AU (1) AU2006336002A1 (fr)
BR (1) BRPI0620949A2 (fr)
CA (1) CA2636114A1 (fr)
FR (1) FR2895677B1 (fr)
IL (1) IL192428A0 (fr)
MA (1) MA30035B1 (fr)
NO (1) NO20083307L (fr)
NZ (1) NZ569203A (fr)
RU (1) RU2428170C2 (fr)
TN (1) TNSN08290A1 (fr)
UA (1) UA95790C2 (fr)
WO (1) WO2007083006A2 (fr)
ZA (1) ZA200805112B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2958163B1 (fr) 2010-03-31 2014-06-13 Fabre Pierre Dermo Cosmetique Preparation issue d'une culture in vitro de cellules dedifferencieres non elicitees d'arganier, leur utilisation pour le traitement du vieillissement cutane, de l'inflammation et de la cicatrisation, et leur obtention.
BR112016023890B1 (pt) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc métodos para reduzir sinais de envelhecimento da pele, para aumentar a adipogênese da face e do corpo e para aumentar a lipogênese da face e do corpo
KR101734801B1 (ko) 2014-04-30 2017-05-11 킴벌리-클라크 월드와이드, 인크. 추출물들의 조합을 이용한 피부 노화 징후 감소 방법
KR102232374B1 (ko) 2014-04-30 2021-03-26 킴벌리-클라크 월드와이드, 인크. 피부 노화의 징후를 감소시키기 위해 지방생성 및 지질생성을 자극하기 위한 국소 조성물
AU2014392629B2 (en) 2014-04-30 2021-04-01 Kimberly-Clark Worldwide, Inc. Use of Undaria extract to reduce signs of skin aging
KR101734802B1 (ko) * 2014-04-30 2017-05-11 킴벌리-클라크 월드와이드, 인크. 피부 노화의 징후를 감소시키기 위한 추출물의 조합을 포함하는 국소 조성물
MX2016013135A (es) 2014-04-30 2017-01-20 Kimberly Clark Co Composiciones y metodos para reducir el estres oxidativo.
JP2023162457A (ja) * 2020-09-09 2023-11-09 株式会社Adeka アルガン抽出物の製造方法、アルガン抽出物、発毛促進剤、脱毛予防剤、及び毛周期調節剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702773B1 (fr) * 1993-03-19 1995-06-16 Deslog Procede de preparation de fractions de matieres grasses d'origine vegetale enrichies en matieres insaponifiables.
CN1427707A (zh) * 2000-03-31 2003-07-02 日清制油株式会社 皮肤外用剂和增白剂
EP1213025A1 (fr) * 2000-12-06 2002-06-12 Laboratoires Serobiologiques(Societe Anonyme) Composition cosmétique et/ou dermopharmaceutique conténant un extrait obtenu à partir de feuilles d'Argania spinosa
FR2857596B1 (fr) * 2003-07-18 2006-02-03 Expanscience Lab Utilisation d'une composition cosmetique ou pharmaceutique comprenant un extrait riche en lupeol, a titre de principe actif, pour stimuler la synthese des proteines de stress
WO2005039610A1 (fr) * 2003-10-24 2005-05-06 Cognis France, S.A.S. Extrait vegetal et utilisation pharmaceutique et cosmetique correspondante

Also Published As

Publication number Publication date
CN101355926A (zh) 2009-01-28
BRPI0620949A2 (pt) 2011-11-29
RU2008132144A (ru) 2010-02-10
IL192428A0 (en) 2009-02-11
FR2895677A1 (fr) 2007-07-06
KR20080083134A (ko) 2008-09-16
RU2428170C2 (ru) 2011-09-10
HK1124779A1 (en) 2009-07-24
WO2007083006A2 (fr) 2007-07-26
FR2895677B1 (fr) 2012-05-25
NO20083307L (no) 2008-07-25
TNSN08290A1 (fr) 2009-12-29
AU2006336002A1 (en) 2007-07-26
UA95790C2 (ru) 2011-09-12
WO2007083006A9 (fr) 2007-10-25
ZA200805112B (en) 2009-03-25
US20090012049A1 (en) 2009-01-08
WO2007083006A3 (fr) 2007-09-13
CA2636114A1 (fr) 2007-07-26
JP2009522341A (ja) 2009-06-11
EP1968536A2 (fr) 2008-09-17
NZ569203A (en) 2010-08-27
CN101355926B (zh) 2011-11-16

Similar Documents

Publication Publication Date Title
MA30035B1 (fr) Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane
Cornara et al. Therapeutic properties of bioactive compounds from different honeybee products
FR2949044B1 (fr) Composition comprenant une fraction d'insaponifiable
MA29931B1 (fr) Inhibiteurs de la proteine d'activation de la 5-lipoxygenase (flap)
MA54231B1 (fr) Composés de 2-formyl-3-hydroxyphényloxyméthyle capables de moduler l'hémoglobine
EP1848431A4 (fr) Formulations liquides pour le traitement de maladies ou affections
MA27311A1 (fr) Utilisation d'inhibiteurs de cetp et facultativement d'inhibiteurs de hmg-coa-reductase et/ou d'agents antihypertensifs
WO2011064402A3 (fr) Extrait de graines d'acacia macrostachya et compositions le comprenant
MA35455B1 (fr) (wo2013045407) dérivés d'estra-1,3,5(10),16-tétraène-3-carboxamide, procédé pour leur fabrication, préparations pharmaceutiques contenant ces substances ainsi que leur utilisation dans la fabrication de médicaments
MA32686B1 (fr) Composés, compositions et procédés pour le traitement de maladies de la b-amyloïde et de synucléinopathies
MA43113B1 (fr) Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci
EP3570835A4 (fr) Méthodes et compositions pharmaceutiques pour la prévention ou le traitement d'affections dermiques immuno-inflammatoires
FR3063905B1 (fr) Utilisation de copaifera en cosmetique et en dermatologie
MA29625B1 (fr) Immunoglobulines
FR2865652B1 (fr) Utilisation d'extraits de plantes et de molecules purifiees pour des compositions cosmetique, nutraceutique ou pharmaceutique a action amincissante lipolytique.
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
BR0318686A (pt) formulação de ervas contendo centella asiatica e sesamum indicum como tonico cerebral
Cesnulevicius The Bioregulatory Approach to Work-related Musculoskeletal Disorders: Using the Multicomponent Ultra low-dose Medication Traumeel to Target the Multiple Pathophysiological Processes of the Disease.
MA39406A1 (fr) Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline
FR2938429B1 (fr) Utilisation cosmetique de microorganisme(s) pour le traitement des desordres du cuir chevelu
UA94434C2 (ru) Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит
PT1796702E (pt) Utilização de óleo de lavanda para profilaxia e tratamento de distúrbios de somatização e da doença de stress pós-traumático
MA62939A1 (fr) Composition pharmaceutique de pembrolizumab et son utilisation
EP3677272A4 (fr) Application de alistipes shahii dans la préparation d'une composition pour la prévention et/ou le traitement de maladies associées au métabolisme lipidique
FR2793141B1 (fr) Extrait de bourgeons de peuplier et son association avec le squalane pour son utilisation en tant que medicament anti-inflammatoire et dans un procede de traitement cosmetique